Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ifrah

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|December 1, 1995
Peripheral primitive neuroectodermal tumour after allogeneic bone marrow transplantationE Gamelin, S François, S Guyetant, et al.
Haematology and Blood Transfusion|January 1, 1990
Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemiaJ L Harousseau, N Milpied, J Briere, et al.
Journal of Pediatric Hematology/Oncology|August 1, 1996
Myelodysplastic syndrome with t(5;12)(q31;p12-p13) and eosinophilia: a pediatric case with review of literatureI Pellier, P J Le Moine, X Rialland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabineJ L Harousseau, J Reiffers, P Hurteloup, et al.
Leukemia|September 24, 2004
Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an updateF Lefrère, V Lévy, S François, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosageE Gamelin, M Boisdron-Celle, V Guérin-Meyer, et al.
Annales De Pathologie|January 1, 1995
[Immunohistochemical characterization of acute leukemia. Study of 31 bone marrow biopsies]M C Rousselet, A Laniece, J Gardais, et al.
Genes, Chromosomes & Cancer|August 26, 1998
Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemiaS François, E Delabesse, L Baranger, et al.
Lancet (London, England)|July 25, 1987
Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemiasD Maraninchi, E Gluckman, D Blaise, et al.
Blood|May 15, 1992
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle OsseuseD Blaise, D Maraninchi, E Archimbaud, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|December 1, 1995
Peripheral primitive neuroectodermal tumour after allogeneic bone marrow transplantationE Gamelin, S François, S Guyetant, et al.
Haematology and Blood Transfusion|January 1, 1990
Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemiaJ L Harousseau, N Milpied, J Briere, et al.
Journal of Pediatric Hematology/Oncology|August 1, 1996
Myelodysplastic syndrome with t(5;12)(q31;p12-p13) and eosinophilia: a pediatric case with review of literatureI Pellier, P J Le Moine, X Rialland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabineJ L Harousseau, J Reiffers, P Hurteloup, et al.
Leukemia|September 24, 2004
Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an updateF Lefrère, V Lévy, S François, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosageE Gamelin, M Boisdron-Celle, V Guérin-Meyer, et al.
Annales De Pathologie|January 1, 1995
[Immunohistochemical characterization of acute leukemia. Study of 31 bone marrow biopsies]M C Rousselet, A Laniece, J Gardais, et al.
Genes, Chromosomes & Cancer|August 26, 1998
Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemiaS François, E Delabesse, L Baranger, et al.
Lancet (London, England)|July 25, 1987
Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemiasD Maraninchi, E Gluckman, D Blaise, et al.
Blood|May 15, 1992
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle OsseuseD Blaise, D Maraninchi, E Archimbaud, et al.
Pageof 13